Hafrun Fridriksdottir
Sr VP,Global Generics R&D, Actavis.
Companies
- Teva Pharmaceutical Industries Ltd.Executive VP, Global R&D Jan 2, 2018 to May 19, 20221
- Allergan plcSVP, GLOBAL R&D Oct 3, 2013 to May 13, 20142
- ActavisSr VP,Global Generics R&D Nov 5, 2012 to Oct 2, 20133
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Teva Pharmaceutical Industries Ltd. TEVA1,387 shares4$57.4K at $41.41May 17, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- May 17, 2022Sold 130,000 shares at $8.22 of Teva Pharmaceutical Industries Ltd.4
- Mar 7, 2022Sold 8,941 shares at $7.37 of Teva Pharmaceutical Industries Ltd.5
- Mar 5, 2022Exercised options 23,764 shares of Teva Pharmaceutical Industries Ltd.5
- Mar 4, 2022Sold 6,618 shares at $7.48 of Teva Pharmaceutical Industries Ltd.5
- Mar 4, 2022Exercised options 18,905 shares of Teva Pharmaceutical Industries Ltd.5
- Mar 4, 2022Sold 18,020 shares at $7.48 of Teva Pharmaceutical Industries Ltd.5
- Mar 4, 2022Exercised options 51,488 shares of Teva Pharmaceutical Industries Ltd.5
- Feb 28, 2022Sold 7,590 shares at $8.14 of Teva Pharmaceutical Industries Ltd.6
- Feb 28, 2022Exercised options 21,682 shares of Teva Pharmaceutical Industries Ltd.6
- Feb 9, 2022Sold 6,116 shares at $9.06 of Teva Pharmaceutical Industries Ltd.7
- Feb 9, 2022Exercised options 16,121 shares of Teva Pharmaceutical Industries Ltd.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARAllergan plc, SVP, GLOBAL R&D
- 3SEC EDGARActavis, Sr VP,Global Generics R&D
- 4
- 5SEC EDGARForm 4 filed Mar 8, 2022
- 6SEC EDGARForm 4 filed Mar 2, 2022
- 7SEC EDGARForm 4 filed Feb 10, 2022